|
|
|
|
|
|
|
||
ARTICLE |
Correspondence to Claudio Grosman: grosman{at}life.uiuc.edu
The phenomenon of ligand-induced ion channel gating hinges upon the ability of a receptor channel to bind ligand molecules with conformation-specific affinities. However, our understanding of this fundamental phenomenon is notably limited, not only because the changes in binding site structure and ligand conformation that occur upon gating are largely unknown but, also, because the strength of these ligand–receptor interactions are experimentally elusive. Both high- and low-efficacy ligands pose a number of analytical and experimental challenges that can render the estimation of their conformation-specific binding affinities impossible. In this paper, we present a novel assay that overcomes some of the hurdles presented by weak agonists of the muscle nicotinic receptor and allows the estimation of their closed-state affinities. The method, which we have termed the "activation-competition" assay, consists of a single-channel concentration–response assay performed in the presence of a binary mixture of ligands of widely different efficacies. By plotting the channel response (i.e., the open probability) as a function of the concentration of each agonist in the mixture, interpreting the observed response in the framework of a plausible kinetic scheme, and fitting the open probability surface with the corresponding function, the affinities of the closed receptor for the two agonists can be simultaneously extracted as free parameters. Here, we applied this methodology to estimate the closed-state affinity of the muscle nicotinic receptor for choline (a very weak agonist) using acetylcholine (ACh) as the partner in the mixture. We estimated the dissociation equilibrium constant of choline (KD) from the wild type's closed state to be 4.1 ± 0.5 mM (and that of ACh to be 106 ± 6 µM). We also discuss the use of accurate estimates of affinities for low-efficacy agonists as a tool to discriminate between binding and gating effects of mutations, and in the context of the rational design of therapeutic drugs.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Related Article
This article has been cited by other articles:
|
|
 |
|
  G. A. F. Nievas, F. J. Barrantes, and S. S. Antollini Modulation of Nicotinic Acetylcholine Receptor Conformational State by Free Fatty Acids and Steroids J. Biol. Chem., August 1, 2008; 283(31): 21478 - 21486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Keramidas and N. L. Harrison Agonist-dependent Single Channel Current and Gating in {alpha}4{beta}2{delta} and {alpha}1{beta}2{gamma}2S GABAA Receptors J. Gen. Physiol., January 28, 2008; 131(2): 163 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Solt, D. Ruesch, S. A. Forman, P. A. Davies, and D. E. Raines Differential Effects of Serotonin and Dopamine on Human 5-HT3A Receptor Kinetics: Interpretation within an Allosteric Kinetic Model J. Neurosci., November 28, 2007; 27(48): 13151 - 13160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Elenes, Y. Ni, G. D. Cymes, and C. Grosman Desensitization Contributes to the Synaptic Response of Gain-of-Function Mutants of the Muscle Nicotinic Receptor J. Gen. Physiol., November 1, 2006; 128(5): 615 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Purohit and C. Grosman Block of Muscle Nicotinic Receptors by Choline Suggests that the Activation and Desensitization Gates Act as Distinct Molecular Entities J. Gen. Physiol., May 30, 2006; 127(6): 703 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
